We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+6.76%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.01B
AUM Growth
+$43M
Cap. Flow
-$22.7M
Cap. Flow %
-2.24%
Top 10 Hldgs %
36.11%
Holding
179
New
10
Increased
53
Reduced
44
Closed
13

Top Buys

Rank Stock Value
1
PEP icon
PepsiCo
PEP
+$11.9M
2
META icon
Meta Platforms (Facebook)
META
+$8.37M
3
GSK icon
GSK
GSK
+$4.31M
4
GOOG icon
Alphabet (Google) Class C
GOOG
+$3.85M
5
MSFT icon
Microsoft
MSFT
+$2.88M

Top Sells

Rank Stock Value
1
GEN icon
Gen Digital
GEN
+$13M
2
CSCO icon
Cisco
CSCO
+$9.62M
3
JPM icon
JPMorgan Chase
JPM
+$8.86M
4
SCHW
Charles Schwab
SCHW
+$8.72M
5
IM
Ingram Micro
IM
+$7.03M

Sector Composition

Rank Sector Weight
1 Technology 33.7%
2 Financials 24.98%
3 Healthcare 11.87%
4 Communication Services 11.25%
5 Consumer Discretionary 5.71%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
MRK icon
76
Merck
MRK
$324B
$3.02M 0.3%
53,762
-4,716
-8% -$276K
DVA icon
77
DaVita
DVA
$15.1B
$3.02M 0.3%
47,000
+1,200
+3% +$74.7K
DGX icon
78
Quest Diagnostics
DGX
$25.1B
$2.91M 0.29%
31,700
-300
-0.9% -$25.9K
CSRA
79
DELISTED
CSRA Inc.
CSRA
$2.91M 0.29%
91,431
– –
MRVL icon
80
Marvell Technology
MRVL
$174B
$2.89M 0.29%
208,400
-20,339
-9% -$277K
GNTX icon
81
Gentex
GNTX
$4.88B
$2.87M 0.28%
145,790
+10,260
+8% +$187K
UNH icon
82
UnitedHealth
UNH
$382B
$2.74M 0.27%
17,100
– –
VVX icon
83
V2X
VVX
$2.62B
$2.67M 0.26%
112,179
-5,023
-4% -$102K
AIZ icon
84
Assurant
AIZ
$13.7B
$2.65M 0.26%
28,550
+2,250
+9% +$197K
SNY icon
85
Sanofi
SNY
$104B
$2.64M 0.26%
65,200
– –
CRUS icon
86
Cirrus Logic
CRUS
$6.74B
$2.54M 0.25%
44,850
-10,600
-19% -$587K
STJ
87
DELISTED
St Jude Medical
STJ
$2.53M 0.25%
31,500
– –
JNJ icon
88
Johnson & Johnson
JNJ
$635B
$2.5M 0.25%
21,700
– –
AET
89
DELISTED
Aetna Inc
AET
$2.5M 0.25%
20,160
– –
SYK icon
90
Stryker
SYK
$127B
$2.43M 0.24%
20,300
-2,650
-12% -$305K
BIIB icon
91
Biogen
BIIB
$29.9B
$2.38M 0.23%
8,380
+430
+5% +$127K
CSGS
92
DELISTED
CSG Systems International
CSGS
$2.37M 0.23%
48,874
+575
+1% +$24.7K
CRL icon
93
Charles River Laboratories
CRL
$10.9B
$2.32M 0.23%
30,400
-1,200
-4% -$91.1K
NOC icon
94
Northrop Grumman
NOC
$77B
$2.29M 0.23%
9,850
-1,609
-14% -$374K
ENDP
95
DELISTED
Endo International plc
ENDP
$2.28M 0.23%
138,570
+42,870
+45% +$754K
GSBC icon
96
Great Southern Bancorp
GSBC
$863M
$2.27M 0.22%
41,552
-16,687
-29% -$790K
CI icon
97
Cigna
CI
$76.6B
$1.87M 0.18%
14,000
– –
WOOF
98
DELISTED
VCA Inc.
WOOF
$1.76M 0.17%
25,700
-12,900
-33% -$842K
LLY icon
99
Eli Lilly
LLY
$1.07T
$1.66M 0.16%
22,500
– –
MDT icon
100
Medtronic
MDT
$107B
$1.55M 0.15%
21,742
-5,676
-21% -$446K
2 3
4
5 6

Similar funds

FAT
First American Trust Santa Ana, California $1.49B AUM 21.98% 1-Year Est. Return
AIA
Ally Invest Advisors Charlotte, North Carolina $1.49B AUM 14.08% 1-Year Est. Return
LFS
Lutz Financial Services Omaha, Nebraska $1.49B AUM 10.4% 1-Year Est. Return
PIM
Plato Investment Management Sydney, NSW, Australia $1.49B AUM 28.65% 1-Year Est. Return
NAM
Nexpoint Asset Management Dallas, Texas $1.49B AUM 61.08% 1-Year Est. Return
RIM
Rush Island Management New York $1.49B AUM 4.65% 1-Year Est. Return
SB
Simmons Bank Pine Bluff, Arkansas $1.49B AUM 23.32% 1-Year Est. Return
MHS
M Holdings Securities Portland, Oregon $1.48B AUM 26.15% 1-Year Est. Return

Oak Associates's Q4 2016 Portfolio in Review

As of Q4 2016, Oak Associates held 179 positions worth $1.01B, up 4.4% from $971M the previous quarter. Its ten largest holdings account for 36% of the portfolio.

Oak Associates's Q4 2016 filing shows 10 new, 53 increased, 44 reduced and 13 closed positions. Its largest new stake was BAYER AG SPONS ADR: 10,800 shares worth $1.13M. The largest sale was Gen Digital, an estimated $13M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 35% a quarter earlier, followed by Financials and Healthcare.

  • Oak Associates's largest Q4 2016 buy was BAYER AG SPONS ADR: 10,800 shares worth $1.13M.
  • Oak Associates added most to PepsiCo in Q4 2016, an estimated $11.9M increase.
  • Oak Associates's biggest Q4 2016 reduction was Gen Digital, cutting an estimated $13M.
  • Oak Associates fully exited Ingram Micro in Q4 2016, selling an estimated $7.03M.
  • Oak Associates's ten largest holdings make up 36% of its $1.01B portfolio in Q4 2016.
  • Oak Associates opened 10 new positions and closed 13 in Q4 2016.
  • Oak Associates's portfolio value rose 4.4% quarter-over-quarter to $1.01B.

Based on Oak Associates's 13F filing for Q4 2016, filed 8 Feb 2017.